Charles Schwab’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$54.7M Sell
515,075
-100,642
-16% -$10.7M 0.01% 1053
2025
Q1
$76.4M Buy
615,717
+200
+0% +$24.8K 0.01% 798
2024
Q4
$75.8M Buy
615,517
+83,807
+16% +$10.3M 0.01% 817
2024
Q3
$59.2M Buy
531,710
+42,587
+9% +$4.74M 0.01% 998
2024
Q2
$52.2M Buy
489,123
+29,179
+6% +$3.11M 0.01% 1041
2024
Q1
$55.4M Sell
459,944
-45,710
-9% -$5.5M 0.01% 969
2023
Q4
$62.2M Sell
505,654
-8,324
-2% -$1.02M 0.02% 822
2023
Q3
$66.5M Buy
513,978
+46,702
+10% +$6.05M 0.02% 712
2023
Q2
$57.9M Buy
467,276
+20,636
+5% +$2.56M 0.02% 776
2023
Q1
$65.4M Buy
446,640
+23,963
+6% +$3.51M 0.02% 660
2022
Q4
$67.3M Buy
422,677
+20,797
+5% +$3.31M 0.02% 638
2022
Q3
$53.6M Buy
401,880
+44,739
+13% +$5.96M 0.02% 713
2022
Q2
$55.7M Buy
357,141
+10,415
+3% +$1.62M 0.02% 685
2022
Q1
$54M Buy
346,726
+12,733
+4% +$1.98M 0.02% 824
2021
Q4
$42.6M Buy
333,993
+15,435
+5% +$1.97M 0.01% 1016
2021
Q3
$41.5M Sell
318,558
-4,558
-1% -$594K 0.01% 1007
2021
Q2
$57.4M Buy
323,116
+37,740
+13% +$6.7M 0.02% 777
2021
Q1
$46.9M Buy
285,376
+7,984
+3% +$1.31M 0.02% 877
2020
Q4
$45.8M Buy
277,392
+5,624
+2% +$928K 0.02% 820
2020
Q3
$38.8M Sell
271,768
-86,589
-24% -$12.3M 0.02% 794
2020
Q2
$39.5M Sell
358,357
-126,505
-26% -$14M 0.02% 722
2020
Q1
$48.4M Sell
484,862
-54,308
-10% -$5.42M 0.03% 539
2019
Q4
$80.5M Buy
539,170
+57,710
+12% +$8.62M 0.04% 408
2019
Q3
$61.7M Buy
481,460
+24,234
+5% +$3.11M 0.04% 478
2019
Q2
$65.2M Buy
457,226
+9,797
+2% +$1.4M 0.04% 446
2019
Q1
$64M Buy
447,429
+3,099
+0.7% +$443K 0.04% 428
2018
Q4
$55.1M Buy
444,330
+27,247
+7% +$3.38M 0.04% 409
2018
Q3
$70.1M Buy
417,083
+156,315
+60% +$26.3M 0.05% 383
2018
Q2
$44.9M Buy
260,768
+42,463
+19% +$7.32M 0.03% 558
2018
Q1
$33M Buy
218,305
+11,355
+5% +$1.71M 0.03% 690
2017
Q4
$27.9M Buy
206,950
+9,856
+5% +$1.33M 0.02% 745
2017
Q3
$28.8M Buy
197,094
+11,428
+6% +$1.67M 0.03% 663
2017
Q2
$28.9M Buy
185,666
+10,446
+6% +$1.62M 0.03% 614
2017
Q1
$25.4M Buy
175,220
+9,693
+6% +$1.41M 0.03% 673
2016
Q4
$18M Buy
165,527
+7,469
+5% +$814K 0.02% 816
2016
Q3
$19.2M Sell
158,058
-96,273
-38% -$11.7M 0.02% 703
2016
Q2
$35.9M Buy
254,331
+54,790
+27% +$7.74M 0.05% 410
2016
Q1
$26.1M Buy
199,541
+13,644
+7% +$1.78M 0.03% 510
2015
Q4
$26.1M Buy
185,897
+23,624
+15% +$3.32M 0.04% 491
2015
Q3
$21.6M Buy
162,273
+18,359
+13% +$2.44M 0.03% 528
2015
Q2
$25.3M Buy
143,914
+36,544
+34% +$6.43M 0.04% 476
2015
Q1
$18.6M Buy
107,370
+11,045
+11% +$1.91M 0.03% 596
2014
Q4
$15.8M Buy
96,325
+8,233
+9% +$1.35M 0.02% 605
2014
Q3
$14.1M Sell
88,092
-16,185
-16% -$2.6M 0.02% 613
2014
Q2
$15.3M Buy
104,277
+3,026
+3% +$445K 0.03% 571
2014
Q1
$14M Buy
101,251
+9,099
+10% +$1.26M 0.03% 596
2013
Q4
$11.7M Buy
92,152
+7,302
+9% +$924K 0.02% 628
2013
Q3
$7.74M Buy
84,850
+11,181
+15% +$1.02M 0.02% 804
2013
Q2
$5.14M Buy
+73,669
New +$5.14M 0.01% 1025